Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Eastern Cooperative Oncology Group
Colorado State University
AIDS Malignancy Consortium
Zagazig University
University Health Network, Toronto
Essen Biotech
Brigham and Women's Hospital
St. Jude Children's Research Hospital
Institut BergoniƩ
Duke University
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
Adela, Inc
M.D. Anderson Cancer Center
ITM Solucin GmbH
University of Salamanca
AC Camargo Cancer Center
National Cancer Institute (NCI)
University Health Network, Toronto
St. Jude Children's Research Hospital
Incyte Corporation
Immunitas Therapeutics
M.D. Anderson Cancer Center
Young Adult Survivors United
IRCCS San Raffaele
Cook Group Incorporated
Arab American University (Palestine)
National Cancer Institute (NCI)
Washington University School of Medicine
Incyte Corporation
AIDS Malignancy Consortium
Trishula Therapeutics, Inc.
Institut BergoniƩ
Tempus AI
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Intensity Therapeutics, Inc.
Cedars-Sinai Medical Center
Assistance Publique Hopitaux De Marseille
National Cancer Institute (NCI)
University Health Network, Toronto
Massachusetts General Hospital
University Medicine Greifswald
University of Modena and Reggio Emilia
VitaMed Research LLC
University Medical Center Groningen
Cedars-Sinai Medical Center
National Institutes of Health Clinical Center (CC)
Sanguine Biosciences